ArticleCellular & molecular biology letters2025

CircUCK2(2,3) promotes cancer progression and enhances synergistic cytotoxicity of lenvatinib with EGFR inhibitors via activating CNIH4-TGFα-EGFR signaling.

Xindong Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.